Advertisement

Topics

Isis Innovation Company Profile

09:14 EDT 24th September 2018 | BioPortfolio

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wholly-owned subsidiary of the University of Oxford; it was established in 1988 and in 1997 started a major expansion phase. The University assigns its intellectual property to Isis (where there are no pre-existing exploitation arrangements) and Isis then evaluates, protects, and markets the intellectual property. In 2002, Oxford University Consulting became part of Isis, matching business consulting needs with University researchers.

Location

Ewert House, Ewert Place
Summertown
Oxfordshire
OX2 7SG
United Kingdom

Contact

Phone: 44 (0)1865 280830
Fax: 44 (0)1865 280831
Email: innovation@isis.ox.ac.uk


News Articles [336 Associated News Articles listed on BioPortfolio]

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

Clinical Trials of Isis 2503 Anticancer Compound Initiated

Isis Pharmaceuticals (Carlsbad, CA) has initiated a Phase II clinical trial of Isis 2503, its third antisense anticancer compound in clinical development...

Australian politician compares anti-GMO activists to ISIS

US$ 1.5B Deal, PTV News: Apr 01, 2010

GSK and Isis to develop up to 6 drugs for rare and serious diseases

Cholesterol Hope, PTV News: Mar 18, 2010

Genzyme and Isis announce positive phase III trials for inherited high LDL drug

News Headlines, PTV News: Apr 01, 2010

A look at today's forthcoming news stories: GSK and Isis in US$ 1.5B deal to develop rare disease drugs; sanofi changes direction towards biotechnology, and Glaxo gets approval for Avodart in combinat...

2018 Innovation and Entrepreneurship Fair was Held to Boost Innovation and Entrepreneurship ...

International, professional and marketing level of the Innovation and Entrepreneurship Fair is continuously improving and is becoming the powerful drive to implement the innovation-driven developmen...

News Headlines, PTV News: Mar 18, 2010

A look at today's forthcoming news stories including Genzyme and Isis announcing positive trials for rare cholesterol condition; Novartis wins European approval for meningitis vaccine and the cannabis...

PubMed Articles [233 Associated PubMed Articles listed on BioPortfolio]

Injury and death during the ISIS occupation of Mosul and its liberation: Results from a 40-cluster household survey.

Measurement of mortality and injury in conflict situations presents many challenges compared with stable situations. However, providing information is important to assess the impact of conflict on pop...

Truck attack: Fear of ISIS and reminder of truck attacks in Europe as associated with psychological distress and PTSD symptoms.

Following an ISIS attack, the present study examined the association between psychological distress and severe stress symptoms with vulnerability variables: i.e. Physical proximity to the site of the ...

Associations between dairy cow inter-service interval and probability of conception.

Recent research has indicated that the interval between inseminations in modern dairy cattle is often longer than the commonly accepted cycle length of 18-24 days. This study analysed 257,396 insemina...

Defining Innovation in Neurosurgery: Results from an International Survey.

Innovation is a part of the daily practice of neurosurgery. A clear definition of what constitutes innovation is currently lacking, however, and opinions vary from continent to continent, from hospita...

Effect of innovation capacity, production capacity and vertical specialization on innovation performance in China's electronic manufacturing: Analysis from the supply and demand sides.

Manufacturing in China has developed rapidly with the widening and deepening of globalization, but only innovation can industry keep upgrading and enhancing its international competitiveness. This pap...

Clinical Trials [182 Associated Clinical Trials listed on BioPortfolio]

A Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of ISIS 353512, to evaluate the blood concentration and rate elimination of ISIS 353512 fr...

Dose-Escalating Safety Study in Subjects on Stable Statin Therapy

The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.

Study of ISIS 301012 in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as add-on therapy in subjects with Heterozygous Familial Hypercholesterolemia

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwis...

A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

The primary objective of the study is to examine the efficacy of multiple doses of ISIS SMNRx (ISIS 396443) administered intrathecally in preventing or delaying the need for respiratory in...

Companies [969 Associated Companies listed on BioPortfolio]

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Isis Parenting Inc.

Isis Parenting is the nation’s leading provider of prenatal and early parenting education. Isis partners with leading healthcare institutions to offer over their patients ove...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-b...

Isis Pharmaceuticals, Inc.

More Information about "Isis Innovation" on BioPortfolio

We have published hundreds of Isis Innovation news stories on BioPortfolio along with dozens of Isis Innovation Clinical Trials and PubMed Articles about Isis Innovation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Isis Innovation Companies in our database. You can also find out about relevant Isis Innovation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record